Thank you to everyone who joined us in Vienna, Austria on Saturday, 7 September 2024 for our OSIC Member Meeting & AI / Biomarker Innovation Showcase.
During this collaborative forum, attendees:
- Listened to, learned from, and asked questions of OSIC members who presented their quantifiable AI advances and emerging innovations using the OSIC data.
- Learned about benefits of the new OSIC Cloud Data Repository, powered by VIDA, including easier contribution of data, robust new filters for cohort selection, collaboration tools to support data sharing.
- Discussed the robust clinical data curation, global normalization, and advanced data power to drive radical progress in drug development for fibrosing lung diseases.
- Had a dialog about the inclusion of new cohorts, including lung cancer screening scans to look for ILAs and ILDs, sarcoidosis, alpha-1.
- Learned about Project OPUS, a new, real-time observational study that applies AI and machine learning technology to the spirometry, environmental and imaging data.
- Participated in a panel discussion on “Making Meaningful Progress in Digital Biomarkers and AI for ILD, and Identifying What More OSIC Can Do.”
Our Event Presenters
DR. SANAZ BERAHMANI
Thirona Business Development Manager |
DR. JONAS BIEHLER
Ebenbuild Chief Technology Officer |
DR. ALEXANDRE COIMBRA
Genentech Director, Clinical Imaging |
EAMONN COSTELLO
patientMpower Chief Executive Officer |
DR. JAN DE BACKER
FLUIDDA Chief Executive Officer |
DR. PETER GEORGE
Brainomix
Senior Medical Director Royal Brompton Hospital Consultant Respiratory Physician & Clinical Lead for ILD |
DAVID HANNES
imbio Chief Executive Officer |
PROF. GEORG LANGS
contextflow
Chief Scientist & Co‑Founder Medical University of Vienna Professor of Machine Learning in Medical Imaging |
DR. JOSHUA REICHER
IMVARIA Co-Founder, CEO and Chairman |
TRICHA SHIVAS
Foundation for Sarcoidosis‑Research Chief of Staff and Strategy |
SANDRA STAPLETON
VIDA Chief Operating Officer |
DR. ALEXANDER C. WHITEHEAD
University College London & OSIC computational science‑team |
Our Panel Discussion Thought Leaders
DR. KEVIN BROWN
National Jewish Health & OSIC pulmonology lead |
PROF. DAVID BARBER
University College of London & OSIC computational science lead |
DR. PETER GEORGE
Brainomix Senior Medical Director Royal Brompton Hospital Consultant Respiratory Physician & Clinical Lead for ILD |
DAVID HANNES
imbio Chief Executive Officer |
DR. ROZSA SCHLENKER-HERCEG
CSL Behring VP, Head of Clinical Development |
